Difference between revisions of "Part:BBa K4040014"
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K4040014 short</partinfo>
 
<partinfo>BBa_K4040014 short</partinfo>
−
 
+
===Sequence and Features===
−
We used CD8a signal peptide to build the synthetic receptors.
+
<partinfo>BBa_K4040014 SequenceAndFeatures</partinfo>
 +
We used the CD8a signal peptide to build the synthetic receptors. Synthetic receptors contained the human CD8a signal peptide followed by the scFv linked in-frame to the hinge domain of the CD8a molecule, transmembrane region of the human CD8 molecule,
 +
and intracellular signaling domains of the FCER1G, MEGF10, MERTK or CD3z molecules.
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
 
===Usage and Biology===
 
===Usage and Biology===
  
 
<!-- -->
 
<!-- -->
−
===Sequence and Features===
+
 
−
<partinfo>BBa_K4040014 SequenceAndFeatures</partinfo>
+
  
  

Latest revision as of 11:41, 4 October 2021


CD8a signal peptide

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

We used the CD8a signal peptide to build the synthetic receptors. Synthetic receptors contained the human CD8a signal peptide followed by the scFv linked in-frame to the hinge domain of the CD8a molecule, transmembrane region of the human CD8 molecule, and intracellular signaling domains of the FCER1G, MEGF10, MERTK or CD3z molecules.